Literature DB >> 10048606

Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia.

M J Wolf1, B Wolf, G Beunen, P Casaer.   

Abstract

UNLABELLED: The study concentrates on estimating the magnitude of the effect of a single risk factor, maximum total serum bilirubin (TSB) in excess of 400 micromol/l (23.4 mg/dl), on the neurodevelopmental outcome of 50, singleton, Zimbabwean neonates at 1 year of age. At 1 year corrected age the Bayley Scales of Infant Development (BSID) was administered. Two infants died and five were lost to follow up. TSB was neither associated with birth weight nor with gestational age. Of 43 infants with a TSB > 400 micromol/l (23.4 mg/dl),11(26%) scored abnormal on the BSID at 1 year of age and 5 (12%) infants developed the choreoathetoid type of cerebral palsy.
CONCLUSION: Infants with bilirubin levels between 400 and 500 micromol/l (23.4 and 29.2 mg/dl) who scored abnormal or suspect on the Bayley Scales of Infant Development were preterm or had haemolytic disease. All term infants without haemolysis and with bilirubin levels between 400 and 500 micromol/l (23.4 mg/dl-29.2 mg/dl) were normal at 1 year of age.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Bilirubinemia; Biology; Child Development; Demographic Factors; Developing Countries; Eastern Africa; English Speaking Africa; Hemic System; Infant; Physiology; Population; Population Characteristics; Prospective Studies; Research Methodology; Research Report; Risk Factors; Studies; Youth; Zimbabwe

Mesh:

Substances:

Year:  1999        PMID: 10048606     DOI: 10.1007/s004310051029

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

Review 1.  Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes.

Authors:  Courtney J Wusthoff; Irene M Loe
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-10       Impact factor: 3.926

2.  Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy.

Authors:  Iman Iskander; Rasha Gamaleldin; Salma El Houchi; Amira El Shenawy; Iman Seoud; Nesrin El Gharbawi; Hazem Abou-Youssef; Aleksandr Aravkin; Richard P Wennberg
Journal:  Pediatrics       Date:  2014-10-20       Impact factor: 7.124

Review 3.  Survival, morbidity, growth and developmental delay for babies born preterm in low and middle income countries - a systematic review of outcomes measured.

Authors:  Melissa Gladstone; Clare Oliver; Nynke Van den Broek
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  Long-term neurocognitive and educational outcomes of neonatal insults in Kilifi, Kenya.

Authors:  Dorcas N Magai; Hans M Koot; Paul Mwangi; Esther Chongwo; Charles R Newton; Amina Abubakar
Journal:  BMC Psychiatry       Date:  2020-12-02       Impact factor: 3.630

5.  Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial.

Authors:  Tina M Slusher; Bolajoko O Olusanya; Hendrik J Vreman; Ronald J Wong; Ann M Brearley; Yvonne E Vaucher; David K Stevenson
Journal:  Trials       Date:  2013-12-28       Impact factor: 2.279

6.  Long-term outcomes of survivors of neonatal insults: A systematic review and meta-analysis.

Authors:  Dorcas N Magai; Eirini Karyotaki; Agnes M Mutua; Esther Chongwo; Carophine Nasambu; Derrick Ssewanyana; Charles R Newton; Hans M Koot; Amina Abubakar
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

7.  Neonatal jaundice and developmental impairment among infants in Kilifi, Kenya.

Authors:  Dorcas N Magai; Michael Mwaniki; Amina Abubakar; Shebe Mohammed; Anne L Gordon; Raphael Kalu; Paul Mwangi; Hans M Koot; Charles R Newton
Journal:  Child Care Health Dev       Date:  2020-02-05       Impact factor: 2.943

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.